Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Atherosclerosis

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.atherosclerosis.2015.10.022PMID 26523994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.

  2015cited by this paper
• Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease.

  2014cited by this paper
• Relation of genetic profile and novel circulating biomarkers with coronary plaque phenotype as determined by intravascular ultrasound: rationale and design of the ATHEROREMO-IVUS study.

  2014cited by this paper
• In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study.

  2014cited by this paper
• Molecular Lipids Identify Cardiovascular Risk and Are Efficiently Lowered by Simvastatin and PCSK9 Deficiency

  2013influential reference
• Distance of lipid core-rich plaques from the ostium by NIRS in nonculprit coronary arteries.

  2012cited by this paper
• Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS/MS.

  2012cited by this paper
• Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study.

  2011cited by this paper
• High throughput quantitative molecular lipidomics.

  2011cited by this paper
• A prospective natural-history study of coronary atherosclerosis.

  2011cited by this paper
• The human plasma lipidome.

  2011cited by this paper
• Plasma Lipidomic Analysis of Stable and Unstable Coronary Artery Disease

  2011cited by this paper
• Comparative Lipidomics Profiling of Human Atherosclerotic Plaques

  2011cited by this paper
• Imaging of coronary atherosclerosis: intravascular ultrasound.

  2010cited by this paper
• Inhibition of Glycosphingolipid Synthesis Induces a Profound Reduction of Plasma Cholesterol and Inhibits Atherosclerosis Development in APOE*3 Leiden and Low-Density Lipoprotein Receptor−/− Mice

  2010cited by this paper
• High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry.

  2009cited by this paper
• Ceramide: a common pathway for atherosclerosis?

  2008cited by this paper
• Sphingolipid metabolizing enzymes as novel therapeutic targets.

  2008cited by this paper
• Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system.

  2008cited by this paper
• Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation.

  2007cited by this paper
• Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound.

  2006cited by this paper
• Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning.

  2006cited by this paper
• Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry.

  2005cited by this paper
• Effect of Myriocin on Plasma Sphingolipid Metabolism and Atherosclerosis in apoE-deficient Mice*

  2005cited by this paper
• Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.

  2002cited by this paper
• Quantitative profiling of phospholipids by multiple precursor ion scanning on a hybrid quadrupole time-of-flight mass spectrometer.

  2002cited by this paper
• Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues.

  1997cited by this paper

• Ceramide as a key regulatory factor in the impact of dietary inflammatory index on plaque stability

  2026cites this paper
• Circulating biomarkers: Facilitating the diagnosis and treatment of cancer and other chronic diseases.

  2026cites this paper
• The Role of Ceramides in Metabolic and Cardiovascular Diseases

  2026cites this paper
• Circulating ceramides and sphingomyelins: key biomarkers and targets in cardiovascular prevention.

  2026cites this paper
• Plasma ceramides decreased in Gilbert's syndrome associated with healthy blood lipid phenotypes: A cross-sectional study.

  2026cites this paper
• Characterizing lipoprotein profiles in coronary atherosclerosis development through quantitative lipidomics and proteomics approaches

  2025cites this paper
• Blood metabolome of cardiovascular disease, diabetic kidney disease, and diabetic retinopathy in type 2 diabetes patients: A systematic review and meta-analysis

  2025cites this paper
• Ceramide as a Promising Tool for Diagnosis and Treatment of Clinical Diseases: A Review of Recent Advances

  2025cites this paper
• Ceramide in Coronary Artery Disease: Troublesome or Helpful Future Tools in the Assessment of Risk Prediction and Therapy Effectiveness?

  2025cites this paper
• Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets

  2025cites this paper
• Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics

  2025cites this paper
• Dysregulated Lipid Metabolism as a Central Driver of Atherosclerotic Plaque Pathology

  2025cites this paper
• Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases

  2025cites this paper
• HDL-associated phosphatidylserine blunts myeloid activation and protects from atherosclerosis

  2025cites this paper
• Identification of Plasma Lipidomic Signatures Associated with Coronary Plaque Vulnerability

  2025cites this paper
• Ceramide-based risk score: A novel laboratory tool for cardiovascular risk stratification in hyperuricemia and gout.

  2025cites this paper
• Ceramides as Emerging Players in Cardiovascular Disease: Focus on Their Pathogenetic Effects and Regulation by Diet

  2024influential citation
• Integrating the GRACE Score with the Ceramide Risk Score Enhances the Predictive Accuracy of Major Adverse Cardiac Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

  2024cites this paper
• Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies

  2024cites this paper
• Combined diet and exercise training decreases serum lipids associated with insulin resistance

  2024cites this paper
• Ceramides as Biomarkers of Cardiovascular Diseases and Heart Failure

  2024cites this paper
• Association between the plasma ceramide and coronary microvascular resistance

  2024cites this paper
• MALDI versus DESI mass spectrometry imaging of lipids in atherosclerotic plaque.

  2024cites this paper
• Changes in ceramide concentrations and their association with clinical and anamnestic parameters in patients with acute coronary syndrome

  2024cites this paper
• Basal and post-stress ceramide-based risk score CERT1 predicts all-cause mortality and nonfatal myocardial infarction in patients with suspected or established coronary artery disease undergoing stress myocardial perfusion scintigraphy.

  2024cites this paper
• Circulating Sphingolipids and All‐Cause Mortality: The Strong Heart Family Study

  2024cites this paper
• Phospholipid biomarkers of coronary heart disease

  2024cites this paper
• Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes.

  2024cites this paper
• The Essence of Lipoproteins in Cardiovascular Health and Diseases Treated by Photodynamic Therapy

  2024cites this paper
• Vitamin D and Ceramide Metabolomic Profile in Acute Myocardial Infarction

  2024cites this paper
• Adiponectin overexpression improves metabolic abnormalities caused by acid ceramidase deficiency but does not prolong lifespan in a mouse model of Farber Disease

  2024cites this paper
• Examining the relationship between the atherogenic index of plasma and coronary plaque burden: insights from a retrospective intravascular ultrasound analysis

  2024cites this paper
• Plasma lipidomics and coronary plaque changes: a substudy of the SMARTool clinical trial

  2024cites this paper
• Ceramides are Fuel Gauges on the Drive to Cardiometabolic Disease.

  2024cites this paper
• Ceramides and pro-inflammatory cytokines for the prediction of acute coronary syndrome: a multi-marker approach

  2024influential citation
• Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability

  2023cites this paper
• Identifying lipid traces of atherogenic mechanisms in human carotid plaque.

  2023cites this paper
• Dysregulation of Ceramide Metabolism Is Linked to Iron Deposition and Activation of Related Pathways in the Aorta of Atherosclerotic Miniature Pigs

  2023cites this paper
• Coronary Event Risk Test (CERT) as a Risk Predictor for the 10-Year Clinical Outcome of Patients with Peripheral Artery Disease

  2023cites this paper
• Longitudinal lipidomic signature of carotid atherosclerosis in American Indians: Findings from the Strong Heart Family Study.

  2023cites this paper
• Effect of different coronary artery revascularization procedures on cognition: A systematic review

  2023cites this paper
• Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction

  2023cites this paper
• Progress in the Metabolomics of Acute Coronary Syndrome

  2023cites this paper
• Cardiomyocytes, sphingolipids and cardio myotoxicity

  2023cites this paper
• Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a “Biochemical” Diagnosis of Metabolic Syndrome?

  2023cites this paper
• Long- and very long-chain ceramides are predictors of acute kidney injury in patients with acute coronary syndrome: the PEACP study

  2023cites this paper
• Association Between Plasma Ceramides and One-Year Mortality in Patients with Acute Coronary Syndrome: Insight from the PEACP Study

  2023cites this paper
• Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis

  2023cites this paper
• Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate

  2023cites this paper
• Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID-19 syndrome with and without postural orthostatic tachycardia syndrome: a multi-omic profiling study

  2023cites this paper
• Differences in the Distribution of Ceramides and Sphingosine among Lipoprotein and Lipoprotein-Depleted Fractions in Patients with Type 2 Diabetes Mellitus

  2022cites this paper
• Sphingolipid Profiling: A Promising Tool for Stratifying the Metabolic Syndrome-Associated Risk

  2022cites this paper
• Sphingolipid metabolism and signaling in cardiovascular diseases

  2022cites this paper
• Serum dihydroceramides correlate with insulin sensitivity in humans and decrease insulin sensitivity in vitro

  2022cites this paper
• Plasma Ceramides in Cardiovascular Disease Risk Stratification

  2022cites this paper
• Radial Wall Strain Assessment From AI-Assisted Angiography: Feasibility and Agreement With OCT as Reference Standard

  2022cites this paper
• Circulating Biomarkers for Laboratory Diagnostics of Atherosclerosis—Literature Review

  2022cites this paper
• Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes

  2022cites this paper
• Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report

  2022cites this paper
• Crosstalk Between Adipose Tissue and the Heart: An Update

  2022cites this paper
• Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasma

  2022cites this paper
• Ceramidas Plasmáticas na Estratificação de Risco das Doenças Cardiovasculares

  2022cites this paper
• De Novo Sphingolipid Biosynthesis in Atherosclerosis.

  2022cites this paper
• Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy

  2022cites this paper
• Plasma Ceramide Levels Are Elevated in Patients With Early Coronary Atherosclerosis and Endothelial Dysfunction

  2022cites this paper
• Equivalent Carbon Number and Interclass Retention Time Conversion Enhance Lipid Identification in Untargeted Clinical Lipidomics.

  2022cites this paper
• The Biological Variability of Plasma Ceramides in Healthy Subjects.

  2022cites this paper
• Small LDL subfractions are associated with coronary atherosclerosis despite no differences in conventional lipids.

  2022cites this paper
• Lipid Metabolite Biomarkers in Cardiovascular Disease: Discovery and Biomechanism Translation from Human Studies

  2021cites this paper
• Sex differences in the association of sphingolipids with age in Dutch and South-Asian Surinamese living in Amsterdam, the Netherlands

  2021cites this paper
• Integrating lipidomics and genomics: emerging tools to understand cardiovascular diseases

  2021cites this paper
• Plasma ceramides are associated with outcomes in acute ischemic stroke patients.

  2021cites this paper
• Serum Ceramides as Prognostic Biomarkers of Large Thrombus Burden in Patients with STEMI: A Micro-Computed Tomography Study

  2021cites this paper
• Lipid signature of advanced human carotid atherosclerosis assessed by mass spectrometry imaging

  2021cites this paper
• Shotgun mass spectrometry-based lipid profiling identifies and distinguishes between chronic inflammatory diseases

  2021cites this paper
• Ceramides and other sphingolipids as drivers of cardiovascular disease

  2021cites this paper
• Bioactive Sphingolipids as Major Regulators of Coronary Artery Disease

  2021cites this paper
• Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis.

  2021cites this paper
• Evaluation of Two Highly Effective Lipid-Lowering Therapies in Subjects With Acute Myocardial Infarction: A Lipidomic Analysis

  2021cites this paper
• Development and validation of a RPLC-MS/MS method for the quantification of ceramides in human serum.

  2021cites this paper
• Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies.

  2021cites this paper
• Plasma ceramides and cardiovascular events in hypertensive patients at high cardiovascular risk.

  2021cites this paper
• Risk factor management and OCT characteristics of plaque vulnerability: the Holy Grail of plaque and patient vulnerability

  2021cites this paper
• Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value

  2021cites this paper
• Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?

  2021cites this paper
• Lipid profiles of patients with manifest coronary versus peripheral atherosclerosis – Is there a difference?

  2021cites this paper
• Comparison of recent ceramide-based coronary risk prediction scores in cardiovascular disease patients.

  2021cites this paper
• Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

  2021cites this paper
• Effective Carbon Number and Inter-Class Retention Time Conversion Enhances Lipid Identifications in Untargeted Clinical Lipidomics

  2021cites this paper
• Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study.

  2021cites this paper
• The Complex Tail of Circulating Sphingolipids in Atherosclerosis and Cardiovascular Disease

  2021cites this paper
• Defining Acute Coronary Syndrome through Metabolomics

  2021influential citation
• A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome.

  2021cites this paper
• Heritability and family-based GWAS analyses of the N-acyl ethanolamine and ceramide plasma lipidome

  2021cites this paper
• Evaluation of two highly effective lipid-lowering therapies in subjects with acute myocardial infarction

  2021cites this paper
• Lipid biomarkers in statin users with coronary artery disease annotated by coronary computed tomography angiography

  2021cites this paper
• Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome.

  2020cites this paper
• Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.

  2020cites this paper
• Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography.

  2020cites this paper
• Lipid signature of advanced human carotid atherosclerosis assessed by mass spectrometry imaging.

  2020cites this paper